Published in J Infect Dis on May 01, 1999
Infection control in cystic fibrosis. Clin Microbiol Rev (2004) 2.45
Clinical significance of microbial infection and adaptation in cystic fibrosis. Clin Microbiol Rev (2011) 2.23
Multilocus sequence typing scheme that provides both species and strain differentiation for the Burkholderia cepacia complex. J Clin Microbiol (2005) 2.17
Species abundance and diversity of Burkholderia cepacia complex in the environment. Appl Environ Microbiol (2005) 1.62
Burkholderia cepacia complex infection in Italian patients with cystic fibrosis: prevalence, epidemiology, and genomovar status. J Clin Microbiol (2001) 1.50
Comparative analysis of plant and animal models for characterization of Burkholderia cepacia virulence. Infect Immun (2003) 1.41
Molecular analysis of Burkholderia cepacia complex isolates from a Portuguese cystic fibrosis center: a 7-year study. J Clin Microbiol (2003) 1.37
Studies on the involvement of the exopolysaccharide produced by cystic fibrosis-associated isolates of the Burkholderia cepacia complex in biofilm formation and in persistence of respiratory infections. J Clin Microbiol (2004) 1.33
The mgtC gene of Burkholderia cenocepacia is required for growth under magnesium limitation conditions and intracellular survival in macrophages. Infect Immun (2006) 1.22
Molecular typing and exopolysaccharide biosynthesis of Burkholderia cepacia isolates from a Portuguese cystic fibrosis center. J Clin Microbiol (2000) 1.11
Comparison of rapid, automated ribotyping and DNA macrorestriction analysis of Burkholderia pseudomallei. J Clin Microbiol (2002) 1.06
Six-year molecular analysis of Burkholderia cepacia complex isolates among cystic fibrosis patients at a referral center for lung transplantation. J Clin Microbiol (2002) 1.06
Outbreak of subclinical mastitis in a flock of dairy sheep associated with Burkholderia cepacia complex infection. J Clin Microbiol (2001) 1.01
Development of a species-specific fur gene-based method for identification of the Burkholderia cepacia complex. J Clin Microbiol (2007) 0.99
Use of suppression-subtractive hybridization to identify genes in the Burkholderia cepacia complex that are unique to Burkholderia cenocepacia. J Bacteriol (2005) 0.96
Functional analysis of Burkholderia cepacia genes bceD and bceF, encoding a phosphotyrosine phosphatase and a tyrosine autokinase, respectively: role in exopolysaccharide biosynthesis and biofilm formation. Appl Environ Microbiol (2006) 0.95
Insights into cross-kingdom plant pathogenic bacteria. Genes (Basel) (2011) 0.89
Infection control in cystic fibrosis: methicillin-resistant Staphylococcus aureus, Pseudomonas aeruginosa and the Burkholderia cepacia complex. J R Soc Med (2000) 0.88
Clinical and environmental Burkholderia strains: biofilm production and intracellular survival. Curr Microbiol (2007) 0.86
rpsU-based discrimination within the genus Burkholderia. Eur J Microbiol Immunol (Bp) (2014) 0.84
Health service careers for people with cystic fibrosis. J R Soc Med (2002) 0.83
Molecular genetic basis of ribotyping. Clin Microbiol Rev (2008) 0.82
Cepacia Syndrome in a Non-Cystic Fibrosis Patient. Case Rep Infect Dis (2015) 0.78
Screening a mushroom extract library for activity against Acinetobacter baumannii and Burkholderia cepacia and the identification of a compound with anti-Burkholderia activity. Ann Clin Microbiol Antimicrob (2010) 0.77
Spontaneous septic arthritis caused by Burkholderia cepacia. Iowa Orthop J (2006) 0.75
New PHA products using unrelated carbon sources. Braz J Microbiol (2011) 0.75
Physical activity in adults with cystic fibrosis receiving intravenous antibiotics in hospital and in the community. Open Respir Med J (2015) 0.75
Can patients with cystic fibrosis have a career in the health service? J R Soc Med (2002) 0.75
Intramural bladder-wall abscess: a late complication arising after a urethrocystoscopy? Pediatr Surg Int (2005) 0.75
How clonal are bacteria? Proc Natl Acad Sci U S A (1993) 18.19
Long-term study of one hundred five patients with cystic fibrosis; studies made over a five- to fourteen-year period. AMA J Dis Child (1958) 9.70
Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J Pediatr (1984) 9.61
Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis. Lancet (1993) 7.12
Person-to-person transmission of Pseudomonas cepacia between patients with cystic fibrosis. Lancet (1990) 4.39
Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome. J Pediatr (1985) 4.26
DNA fingerprinting by pulsed field gel electrophoresis and ribotyping to distinguish Pseudomonas cepacia isolates from a nosocomial outbreak. J Clin Microbiol (1991) 4.20
Burkholderia cepacia: medical, taxonomic and ecological issues. J Med Microbiol (1996) 4.11
Transmissibility of Pseudomonas cepacia infection in clinic patients and lung-transplant recipients with cystic fibrosis. N Engl J Med (1994) 3.89
The emergence of a highly transmissible lineage of cbl+ Pseudomonas (Burkholderia) cepacia causing CF centre epidemics in North America and Britain. Nat Med (1995) 3.36
Linkage analysis of geographic and clinical clusters in Pseudomonas cepacia infections by multilocus enzyme electrophoresis and ribotyping. J Clin Microbiol (1994) 2.74
Ribotype analysis of Pseudomonas cepacia from cystic fibrosis treatment centers. J Pediatr (1988) 2.60
Agricultural use of Burkholderia (Pseudomonas) cepacia: a threat to human health? Emerg Infect Dis (1998) 2.43
Pseudomonas cepacia: biology, mechanisms of virulence, epidemiology. J Pediatr (1986) 2.38
Determinants of mortality from cystic fibrosis in Canada, 1970-1989. Am J Epidemiol (1996) 2.28
Pseudomonas cepacia in inpatients with cystic fibrosis. Lancet (1991) 2.27
Pseudomonas cepacia typing systems: collaborative study to assess their potential in epidemiologic investigations. Rev Infect Dis (1989) 2.25
Multiple replicons constituting the genome of Pseudomonas cepacia 17616. J Bacteriol (1994) 2.21
Case-control and vector studies of nosocomial acquisition of Pseudomonas cepacia in adult patients with cystic fibrosis. Infect Control Hosp Epidemiol (1993) 2.15
An outbreak of Burkholderia (formerly Pseudomonas) cepacia respiratory tract colonization and infection associated with nebulized albuterol therapy. Ann Intern Med (1995) 1.88
Genetic structure of a lotic population of Burkolderia (Pseudomonas) cepacia. Appl Environ Microbiol (1995) 1.80
A physical genome map of the Burkholderia cepacia type strain. Mol Microbiol (1995) 1.73
Comparative evaluation of selective media for isolation of Pseudomonas cepacia from cystic fibrosis patients and environmental sources. J Clin Microbiol (1988) 1.37
Inapparent transmission of Pseudomonas (Burkholderia) cepacia among patients with cystic fibrosis. Pediatr Infect Dis J (1994) 1.34
Structurally variant classes of pilus appendage fibers coexpressed from Burkholderia (Pseudomonas) cepacia. J Bacteriol (1995) 1.24
Auxotrophy of Burkholderia (Pseudomonas) cepacia from cystic fibrosis patients. J Clin Microbiol (1995) 1.14
Genetics for all bacteria. Annu Rev Microbiol (1993) 1.00
Outbreak of Pseudomonas cepacia bacteremia in oncology patients. Clin Infect Dis (1993) 0.95
Identifying the killer in cystic fibrosis. Nat Med (1995) 0.83
The complete genome sequence of Escherichia coli K-12. Science (1997) 84.27
Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat Genet (2001) 63.36
Development and validation of a genetic algorithm for flexible docking. J Mol Biol (1997) 14.36
Resolution of recent evolutionary divergence among Escherichia coli from related lineages: the application of pulsed field electrophoresis to molecular epidemiology. J Infect Dis (1990) 8.33
Recombination within natural populations of pathogenic bacteria: short-term empirical estimates and long-term phylogenetic consequences. Proc Natl Acad Sci U S A (2001) 7.90
The DNA sequence and comparative analysis of human chromosome 20. Nature (2002) 7.40
The EcoCyc and MetaCyc databases. Nucleic Acids Res (2000) 6.14
Organization of the bacterial chromosome. Microbiol Rev (1990) 6.01
Genome sequence of Halobacterium species NRC-1. Proc Natl Acad Sci U S A (2000) 5.87
Physical and chemical characterization of two- and three-stranded adenine-thymine and adenine-uracil homopolymer complexes. J Mol Biol (1966) 5.83
Papers that go beyond numbers (qualitative research) BMJ (1997) 5.48
Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev (2006) 4.80
MultiFun, a multifunctional classification scheme for Escherichia coli K-12 gene products. Microb Comp Genomics (2000) 4.60
Suicide and political regime in New South Wales and Australia during the 20th century. J Epidemiol Community Health (2002) 4.44
Evolution of the bacterial genome. Annu Rev Microbiol (1978) 4.33
Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol. Diabetologia (2011) 3.97
Eco Cyc: encyclopedia of Escherichia coli genes and metabolism. Nucleic Acids Res (1999) 3.90
Transmissibility of Pseudomonas cepacia infection in clinic patients and lung-transplant recipients with cystic fibrosis. N Engl J Med (1994) 3.89
EcoCyc: Encyclopedia of Escherichia coli genes and metabolism. Nucleic Acids Res (1998) 3.80
Effectiveness of programme for reducing cardiovascular risk for men in one general practice. BMJ (1993) 3.59
The packing density in proteins: standard radii and volumes. J Mol Biol (1999) 3.48
The emergence of a highly transmissible lineage of cbl+ Pseudomonas (Burkholderia) cepacia causing CF centre epidemics in North America and Britain. Nat Med (1995) 3.36
Drinking water turbidity and gastrointestinal illness in the elderly of Philadelphia. J Epidemiol Community Health (2000) 3.15
IsoStar: a library of information about nonbonded interactions. J Comput Aided Mol Des (1997) 2.97
Sensitivity to reinforcement in concurrent arithmetic and exponential schedules. J Exp Anal Behav (1983) 2.71
A Prothrombin Conversion Accelerator in Serum. Science (1949) 2.64
Prevalence of diabetes and impaired glucose tolerance in the biracial (Melanesian and Indian) population of Fiji: a rural-urban comparison. Am J Epidemiol (1983) 2.60
EcoCyc: an encyclopedia of Escherichia coli genes and metabolism. Nucleic Acids Res (1996) 2.51
Impacted teeth: prophylactic extractions or not? N Y State Dent J (1995) 2.48
Treating electrical storm : sympathetic blockade versus advanced cardiac life support-guided therapy. Circulation (2000) 2.48
Conservation and variation of nucleotide sequences in Escherichia coli strains isolated from nature. J Bacteriol (1980) 2.45
Agricultural use of Burkholderia (Pseudomonas) cepacia: a threat to human health? Emerg Infect Dis (1998) 2.43
Nobel laureates' letter to President Bush. Washington Post (2001) 2.43
Gene products of Escherichia coli: sequence comparisons and common ancestries. Mol Biol Evol (1995) 2.43
Grading and disease management in national screening for diabetic retinopathy in England and Wales. Diabet Med (2003) 2.40
Periodontitis and diabetes: a two-way relationship. Diabetologia (2011) 2.27
Involvement of XRCC1 and DNA ligase III gene products in DNA base excision repair. J Biol Chem (1997) 2.20
Bronchoalveolar lavage findings suggest two different forms of childhood asthma. Clin Exp Allergy (1997) 2.17
Cable (cbl) type II pili of cystic fibrosis-associated Burkholderia (Pseudomonas) cepacia: nucleotide sequence of the cblA major subunit pilin gene and novel morphology of the assembled appendage fibers. J Bacteriol (1995) 2.16
The evolution and structural anatomy of the small molecule metabolic pathways in Escherichia coli. J Mol Biol (2001) 2.15
PARP alleles within the linked chromosomal region are associated with systemic lupus erythematosus. J Clin Invest (1999) 2.14
A functional update of the Escherichia coli K-12 genome. Genome Biol (2001) 2.12
Molecular epidemiology of adhesin and hemolysin virulence factors among uropathogenic Escherichia coli. Infect Immun (1989) 2.12
Intramuscular triglyceride and muscle insulin sensitivity: evidence for a relationship in nondiabetic subjects. Metabolism (1996) 2.11
Coronary heart disease epidemics: not all the same. Heart (2008) 2.07
Unexpected Ebola virus in a tertiary setting: clinical and epidemiologic aspects. Crit Care Med (2000) 2.03
Medicine as social science: Rudolf Virchow on the typhus epidemic in Upper Silesia. Int J Health Serv (1985) 2.01
Couch or crouch? Examining the prostate: a randomized study comparing the knee-elbow and the left-lateral position. BJU Int (2001) 2.01
Establishing ongoing quality assurance in a retinal screening programme. Diabet Med (2006) 1.98
The effect of combined aerobic and resistance exercise training on vascular function in type 2 diabetes. J Am Coll Cardiol (2001) 1.95
Restriction fragment length polymorphisms among uropathogenic Escherichia coli isolates: pap-related sequences compared with rrn operons. Infect Immun (1990) 1.95
Frequency and predictors of axillary lymph node metastases in invasive breast cancer. ANZ J Surg (2001) 1.93
Biochemical and histological effects of exendin-4 (exenatide) on the rat pancreas. Diabetologia (2009) 1.92
The amino acid sequence of the alpha-chain of human fibrinogen. Nature (1979) 1.92
Effects of an engineered human anti-TNF-alpha antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM. Diabetes (1996) 1.91
A nurse led intermediate care package in patients who have been hospitalised with an acute exacerbation of chronic obstructive pulmonary disease. Thorax (2007) 1.89
URF6, last unidentified reading frame of human mtDNA, codes for an NADH dehydrogenase subunit. Science (1986) 1.87
Conservation and variation of nucleotide sequences within related bacterial genomes: Escherichia coli strains. J Bacteriol (1980) 1.86
Representations of metabolic knowledge. Proc Int Conf Intell Syst Mol Biol (1993) 1.86
The elderly as underconsulters: a critical reappraisal. J R Coll Gen Pract (1985) 1.84
Interpretation of treatment changes in 6-minute walk distance in patients with COPD. Eur Respir J (2008) 1.82
A mutation in guanylate cyclase activator 1A (GUCA1A) in an autosomal dominant cone dystrophy pedigree mapping to a new locus on chromosome 6p21.1. Hum Mol Genet (1998) 1.81
FK506 trough levels in whole blood and plasma in liver transplant recipients. Correlation with clinical events and side effects. Transplantation (1994) 1.80
Stimulation of human leukocyte thromboplastic activity by endotoxin. Proc Soc Exp Biol Med (1971) 1.79
Differential vulnerability of basal and apical hair cells is based on intrinsic susceptibility to free radicals. Hear Res (2001) 1.76
The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40. Blood (2001) 1.75
The effect of intravenous metformin on glucose metabolism during hyperglycaemia in type 2 diabetes. Diabet Med (1992) 1.73
HLA compatibility and liver transplant outcome. Improved patient survival by HLA and cross-matching. Transplantation (1994) 1.71
An evaluation of the Deltatrac indirect calorimeter by gravimetric injection and alcohol burning. Clin Phys Physiol Meas (1991) 1.70
Use of a computer for producing microbiological reports and for data storage and processing. J Clin Pathol (1975) 1.67
Platelet dysfunction in type 2 diabetes. Diabetes Care (2001) 1.66
Predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis. Cancer (1999) 1.66
Composition and dynamics of plasma in Saturn's magnetosphere. Science (2005) 1.66
Skeletal muscle fiber quality in older men and women. Am J Physiol Cell Physiol (2000) 1.66
School-based secondary prevention programmes for preventing violence. Cochrane Database Syst Rev (2006) 1.65
SuperStar: a knowledge-based approach for identifying interaction sites in proteins. J Mol Biol (1999) 1.63
Politics, science, and the emergence of a new disease. The case of chronic fatigue syndrome. Am Psychol (1997) 1.63
Conservation and variation of nucleotide sequences within related bacterial genomes: enterobacteria. J Bacteriol (1980) 1.60
Effect of increased free fatty acid supply on glucose metabolism and skeletal muscle glycogen synthase activity in normal man. Clin Sci (Lond) (1992) 1.60
Lung function in patients with diabetes mellitus. Respir Med (1990) 1.59
Functional components of basic fibroblast growth factor signaling that inhibit lung elastin gene expression. Am J Physiol Lung Cell Mol Physiol (2001) 1.58
Proposal concerning mechanism of evolution of the genome of Escherichia coli. Proc Natl Acad Sci U S A (1975) 1.58
The social context of drinking, drug use, and unsafe sex in the Boston Young Men Study. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 1.58
Suicide and unemployment in Australia 1907-1990. Soc Sci Med (1993) 1.56
Episodic hyperglycaemia in pregnant women with well-controlled Type 1 diabetes mellitus: a major potential factor underlying macrosomia. Diabet Med (1999) 1.56
New ways to look at the architecture of plant cell walls : localization of polygalacturonate blocks in plant tissues. Plant Physiol (1989) 1.55
Autoantibodies to fibrillarin in systemic sclerosis (scleroderma). An immunogenetic, serologic, and clinical analysis. Arthritis Rheum (1996) 1.54
Clinical and clinicopathologic findings in tropical canine pancytopenia. J Am Vet Med Assoc (1970) 1.54
Racial differences in the frequencies of scleroderma-related autoantibodies. Arthritis Rheum (1992) 1.53
Mydriasis and glaucoma: exploding the myth. A systematic review. Diabet Med (2000) 1.52
Fibrinogen levels during trauma hemorrhage, response to replacement therapy, and association with patient outcomes. J Thromb Haemost (2012) 1.51
The evidence base for the cost effectiveness of cardiac rehabilitation. Heart (1997) 1.50
Childhood sexual abuse among homosexual men. Prevalence and association with unsafe sex. J Gen Intern Med (1997) 1.49
Glycerol dehydrogenase. structure, specificity, and mechanism of a family III polyol dehydrogenase. Structure (2001) 1.48